CollPlant Biotechnologies (NASDAQ:CLGN) & Envoy Medical (NASDAQ:COCH) Head-To-Head Analysis

CollPlant Biotechnologies (NASDAQ:CLGN) and Envoy Medical (NASDAQ:COCH) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, dividends, earnings, profitability and risk.

Analyst Recommendations

This is a summary of current ratings and target prices for CollPlant Biotechnologies and Envoy Medical, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CollPlant Biotechnologies	0	0	1	1	3.50
Envoy Medical	0	0	3	0	3.00

CollPlant Biotechnologies currently has a consensus price target of $11.00, indicating a potential upside of 141.23%. Envoy Medical has a consensus price target of $7.25, indicating a potential upside of 216.59%. Given Envoy Medical’s higher probable upside, analysts clearly believe Envoy Medical is more favorable than CollPlant Biotechnologies.

Insider & Institutional Ownership

21.7% of CollPlant Biotechnologies shares are held by institutional investors. Comparatively, 8.6% of Envoy Medical shares are held by institutional investors. 9.6% of CollPlant Biotechnologies shares are held by company insiders. Comparatively, 0.7% of Envoy Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Volatility & Risk

CollPlant Biotechnologies has a beta of 0.24, indicating that its share price is 76% less volatile than the S&P 500. Comparatively, Envoy Medical has a beta of 2.29, indicating that its share price is 129% more volatile than the S&P 500.

Profitability

This table compares CollPlant Biotechnologies and Envoy Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
CollPlant Biotechnologies	-70.58%	-24.74%	-20.90%
Envoy Medical	N/A	N/A	-112.11%

Earnings & Valuation

This table compares CollPlant Biotechnologies and Envoy Medical’s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CollPlant Biotechnologies	$10.96 million	4.76	-$7.02 million	($0.68)	-6.71
Envoy Medical	$297,000.00	151.12	-$29.91 million	N/A	N/A

CollPlant Biotechnologies has higher revenue and earnings than Envoy Medical.

Summary

CollPlant Biotechnologies beats Envoy Medical on 7 of the 13 factors compared between the two stocks.

About CollPlant Biotechnologies

CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. The company's products include BioInks for 3D printing of tissues and organs; dermal filler and soft tissue fillers for treating wrinkles; 3D Bioprinted breast implants for regeneration of breast tissue; VergenixSTR, a soft tissue repair matrix intended for the treatment of tendinopathy; and VergenixFG, an advanced wound care product for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds; as well as develops injectable breast implants and 3D bioprinted regenerative soft tissue matrix for use in breast reconstruction procedures. It has collaboration agreements with Advanced Regenerative Manufacturing Institute; RegenMed Development Organization; International Society for Biofabrication; AbbVie; and STEMCELL Technologies. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. The company was founded in 2004 and is headquartered in Rehovot, Israel.

About Envoy Medical

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.